CN Patent

CN110833549B — 吡唑并嘧啶衍生物在治疗慢性盆腔炎的用途

Assigned to Guangxi Wuzhou Pharmaceutical Group Co Ltd · Expires 2023-05-02 · 3y expired

What this patent protects

本发明涉及药物技术领域，特别是吡唑并嘧啶衍生物在治疗慢性盆腔炎的用途。所述慢性盆腔炎与炎性组织中血液黏度升高，ICAM‑1、FGF‑2表达增强有关。本本发明吡唑并嘧啶衍生物可通过降低血液黏度，抑制组织中ICAM‑1、FGF‑表达等联合作用机制，对慢性盆腔炎产生良好的治疗效果。

USPTO Abstract

本发明涉及药物技术领域，特别是吡唑并嘧啶衍生物在治疗慢性盆腔炎的用途。所述慢性盆腔炎与炎性组织中血液黏度升高，ICAM‑1、FGF‑2表达增强有关。本本发明吡唑并嘧啶衍生物可通过降低血液黏度，抑制组织中ICAM‑1、FGF‑表达等联合作用机制，对慢性盆腔炎产生良好的治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN110833549B
Jurisdiction
CN
Classification
—
Expires
2023-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Guangxi Wuzhou Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.